|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2003-5-26
|
|
pubmed:abstractText |
Restenosis after percutaneous transluminal coronary intervention (PCI) remains a serious complication in the treatment of coronary artery disease. Although beta-adrenergic receptor blockers (BBs) effectively reduce many cardiac events, no large prospective studies have examined the association of BBs with restenosis.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1097-6744
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
145
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
875-81
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:12766747-Adrenergic beta-Antagonists,
pubmed-meshheading:12766747-Angioplasty, Balloon, Coronary,
pubmed-meshheading:12766747-Atherectomy, Coronary,
pubmed-meshheading:12766747-Coronary Restenosis,
pubmed-meshheading:12766747-Coronary Stenosis,
pubmed-meshheading:12766747-Female,
pubmed-meshheading:12766747-Humans,
pubmed-meshheading:12766747-Male,
pubmed-meshheading:12766747-Middle Aged,
pubmed-meshheading:12766747-Odds Ratio,
pubmed-meshheading:12766747-Prospective Studies,
pubmed-meshheading:12766747-Regression Analysis,
pubmed-meshheading:12766747-Stents
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Beta-blockers reduce the incidence of clinical restenosis: prospective study of 4840 patients undergoing percutaneous coronary revascularization.
|
|
pubmed:affiliation |
Division of Cardiology, Department of Medicine, LDS Hospital, Salt Lake City, Utah 84143, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
